Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes

Affiliations

• ¹ Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN jordan.wright@vumc.org al.powers@vanderbilt.edu.
• ² Division of Cardiovascular Medicine and Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
• ³ Department of Pharmacology, Regional Center of Pharmacovigilance, CIC-1421, Pitié-Salpêtrière Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Universities, Paris, France.
• ⁴ Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
• ⁵ Section of Endocrinology, Department of Internal Medicine, Yale University, New Haven, CT.
• ⁶ Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
• ⁷ Department of Immunobiology, Yale University, New Haven, CT.
• ⁸ Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN.
• ⁹ Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN.